<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE309nnn/GSE309464/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309464</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Bulk RNA-seq of EO771 tumor sample Gq_DREADD vs. Ctr</name><description>Bulk RNA-seq was performed to compare mRNA expression in EO771 murine breast tumors between tumors expressing a Gq-DREADD driven CRH-neuron activation paradigm (DCZ injection at in-phase ZT10.5) and matched controls receiving PBS. The goal is to identify transcriptional programs in the tumor that are altered downstream of CRH-neuron activation (acute transcriptional responses, immune/tumor cell signaling, and pathway changes) and generate data suitable for differential expression, pathway enrichment, and hypothesis generation for follow-up functional work.</description><dates><publication>2026/06/18</publication></dates><accession>GSE309464</accession><cross_references><GSM>GSM9267750</GSM><GSM>GSM9267752</GSM><GSM>GSM9267751</GSM><GSM>GSM9267754</GSM><GSM>GSM9267753</GSM><GSM>GSM9267756</GSM><GSM>GSM9267755</GSM><GSM>GSM9267757</GSM><GPL>30172</GPL><GSE>309464</GSE><taxon>Mus musculus</taxon><PMID>[41401811]</PMID></cross_references></HashMap>